In December, Danish hearing aid manufacturers Demant and GN Hearing lost some market shares in the public sales channel in the US, Veterans Affairs (VA), which fits hearing aids for US military veterans. GN Hearing fell to 8.6 percent in December from 8.8 percent in November, and Demant slid back from 15 percent to 14.2 percent in the same periods.
Sivantos, which is part of the merged firm WS Audiology alongside Danish Widex, also saw its VA foothold slightly reduced following a month of considerable forward momentum in November last year, when the company launched the products Signia Pure Charge & Go AX and Signia Insio AX on the market for US veterans.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
(Senior) Drug Substance Specialist 
2 Sales Representatives and Product Specialists 
Senior Chemical Safety Advisor 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Analytical Senior Scientist 
Key Account Manager, Europe and Asia 
Industrial Designer- Design Engineer 
Senior Manager, Clinical Trial Budget 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Communications Consultant 
SAP System Specialist (Product Supply) – Business Application Services 
Biostatistician 
Production Director 
Director for innovative pre-clinical testing unit 
Client Talent Acquisition Specialist 
Senior Project Manager (GMP - Life Science)